FNIP1 gene variant reshapes body fat and muscle, lowering cardiometabolic risk

TL;DR
A large genomics study of over one million people links certain FNIP1 gene variants to more muscle, less belly fat, better glucose metabolism and a substantially lower risk of cardiometabolic diseases such as type 2 diabetes and heart disease, suggesting FNIP1 as a potential target for future therapies.
Want the full story? Read the original reporting
Read on Nature